A Drug Safety and Dose-exploratory Clinical Study of Azvudine Tablets in Patients Who Have Not Received Anti-HIV Treatment

PHASE2CompletedINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

October 10, 2017

Primary Completion Date

January 28, 2019

Study Completion Date

March 6, 2019

Conditions
AIDS
Interventions
DRUG

The subjects were randomized to the treatment group of 3TC or different doses of FNC. The background drugs were EFV and TDF.

The subjects were randomized to the treatment group of 3TC or different doses of FNC. The background drugs were EFV and TDF.

Trial Locations (1)

10000

Beijing YouAn Hospital, Capital Medical University., Beijing

All Listed Sponsors
collaborator

Beijing YouAn Hospital

OTHER

collaborator

Peking Union Medical College Hospital

OTHER

collaborator

Beijing Ditan Hospital

OTHER

collaborator

Guangzhou 8th People's Hospital

OTHER

collaborator

The Sixth People's Hospital of Zhengzhou

OTHER

lead

Henan Genuine Biotech Co., Ltd.

INDUSTRY

NCT04109183 - A Drug Safety and Dose-exploratory Clinical Study of Azvudine Tablets in Patients Who Have Not Received Anti-HIV Treatment | Biotech Hunter | Biotech Hunter